151 related articles for article (PubMed ID: 10515191)
1. LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.
Bond A; Ragumoorthy N; Monn JA; Hicks CA; Ward MA; Lodge D; O'Neill MJ
Neurosci Lett; 1999 Oct; 273(3):191-4. PubMed ID: 10515191
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.
Bond A; Jones NM; Hicks CA; Whiffin GM; Ward MA; O'Neill MF; Kingston AE; Monn JA; Ornstein PL; Schoepp DD; Lodge D; O'Neill MJ
J Pharmacol Exp Ther; 2000 Sep; 294(3):800-9. PubMed ID: 10945827
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia.
Bond A; O'Neill MJ; Hicks CA; Monn JA; Lodge D
Neuroreport; 1998 Apr; 9(6):1191-3. PubMed ID: 9601692
[TBL] [Abstract][Full Text] [Related]
4. Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist.
Cai Z; Xiao F; Fratkin JD; Rhodes PG
Neuroreport; 1999 Dec; 10(18):3927-31. PubMed ID: 10716235
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease.
Murray TK; Messenger MJ; Ward MA; Woodhouse S; Osborne DJ; Duty S; O'Neill MJ
Pharmacol Biochem Behav; 2002 Sep; 73(2):455-66. PubMed ID: 12117601
[TBL] [Abstract][Full Text] [Related]
6. Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia.
Lam AG; Soriano MA; Monn JA; Schoepp DD; Lodge D; McCulloch J
Neurosci Lett; 1998 Sep; 254(2):121-3. PubMed ID: 9779935
[TBL] [Abstract][Full Text] [Related]
7. Effects of LY379268, a selective group II metabotropic glutamate receptor agonist on EEG activity, cortical perfusion, tissue damage, and cortical glutamate, glucose, and lactate levels in brain-injured rats.
Stover JF; Sakowitz OW; Beyer TF; Dohse NK; Kroppenstedt SN; Thomale UW; Schaser KD; Unterberg AW
J Neurotrauma; 2003 Apr; 20(4):315-26. PubMed ID: 12866811
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of the agonist of metabotropic glutamate receptors ABHxD-I in two animal models of cerebral ischaemia.
Makarewicz D; Gadamski R; Ziembowicz A; Kozikowski AP; Wroblewski JT; Lazarewicz JW
Resuscitation; 2006 Jan; 68(1):119-26. PubMed ID: 16325990
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
10. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.
O'Neill MJ; Bogaert L; Hicks CA; Bond A; Ward MA; Ebinger G; Ornstein PL; Michotte Y; Lodge D
Neuropharmacology; 2000 Jul; 39(9):1575-88. PubMed ID: 10854902
[TBL] [Abstract][Full Text] [Related]
11. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
[TBL] [Abstract][Full Text] [Related]
12. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
13. Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the rat.
Lam AG; Monn JA; Schoepp DD; Lodge D; McCulloch J
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1083-91. PubMed ID: 10532632
[TBL] [Abstract][Full Text] [Related]
14. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
Bao WL; Williams AJ; Faden AI; Tortella FC
Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
[TBL] [Abstract][Full Text] [Related]
15. LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia.
O'Neill MJ; Hicks CA; Ward MA; Osborne DJ; Wishart G; Mathews KS; McLaughlin DP; Stamford JA; McCarty DR; Patrick KE; Roman C; Fleisch JH; Gilmore J; Boot JR
Brain Res; 2001 Jan; 888(1):138-149. PubMed ID: 11146060
[TBL] [Abstract][Full Text] [Related]
16. The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats.
Crawford JT; Roberts DC; Beveridge TJ
Drug Alcohol Depend; 2013 Oct; 132(3):414-9. PubMed ID: 23953655
[TBL] [Abstract][Full Text] [Related]
17. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.
Imre G
CNS Drug Rev; 2007; 13(4):444-64. PubMed ID: 18078428
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
Okamura N; Hashimoto K; Shimizu E; Koike K; Ohgake S; Koizumi H; Kumakiri C; Komatsu N; Iyo M
Brain Res; 2003 Nov; 992(1):114-9. PubMed ID: 14604779
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of selective group II mGluR activation in brain trauma and traumatic neuronal injury.
Movsesyan VA; Faden AI
J Neurotrauma; 2006 Feb; 23(2):117-27. PubMed ID: 16503796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
